December 2015 FDA Recall Ventolin by Glaxosmithkline, Llc
D-0519-2016 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Glaxosmithkline, Llc on December 3, 2015 for the product Ventolin. The FDA reported the reason for recall as defective delivery system. The product was distributed in MS and VT and the recall is currently terminated.

Recall Number: D-0519-2016

Reason for Recall
Defective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.
Initiated
12-03-2015
Reported
12-16-2015
Quantity
128,704 Inhalers

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
GlaxoSmithKline, LLC
Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Rx Only, For Oral Inhalation Only, Net Wt. 18 g, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0682-20

Batch or Lot Expiration Information

Lot# s: 5ZP1708, Exp. 12/2016; 5ZP1951, Exp. 02/2017

Affected Packages Involved in this Recall